Dr. Shruti Kate

Introduction

Expertise

• Dr. Shruti’s major areas of interest include gynaecological cancers, genitourinary cancers, thoracic cancers, gastrointestinal cancers and haematological malignancies.
• She has 6 years of experience and is experienced in treating all solid tumours, paediatric tumours, and haematological malignancies.
• Dr. Shruti has a special interest in immunotherapy and metronomic therapy for the treatment of advanced cancers. 
• So far, she has handled more than 50,000 cases.

Recognition

• Dr. Shruti is a member of several reputed national & international oncological societies, such as ASCO, ESMO, IASLC, ISMPO, and IOS.
• She has presented her research on lung cancer in the World Conference on Lung Cancer (WCLC) in Toronto, Canada, and was the sole recipient of a travel award from India in WCLC 2018.

Publications

• Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysis. Lung Cancer (Auckl). 2019 Jan 29;10:1-10.
• Safety and efficacy of scalp cooling system in preventing chemotherapy induced alopecia - A single center prospective study. Cancer Treat Res Commun. 2021;26:100280.
• Evaluation of Prognostic Factors that Affect Survival Outcomes of Breast Cancer Patients with Brain Metastases: A Single Institutional Experience. Eur J Breast Health. 2020 Dec 24;17(1):62-67.
• A Retrospective Analysis of Invasive Fungal Diseases (IFD) of the Central Nervous System in Children With Lymphoid Malignancies. J Pediatr Hematol Oncol. 2020 May;42(4):e202-e206.
• Thromboembolic events in patients with advanced stage non-small cell lung cancer treated with platinum-based chemotherapy: a prospective observational study. Ecancermedicalscience. 2018 Oct 9;12:876.

Other Doctors